| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.13 | 0.02 |